Published: 28 June 2018
Author(s): Michael Medinger, Jakob Passweg
Issue: June 2018
Section: Review Article

Most hematological malignancies are increasing in frequency with age. Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapeutic option for patients with malignant and non-malignant hematological diseases. The treatment of elderly patients with advanced hematological malignancies has expanded to include reduced intensity conditioning allo-HCT. Physicians increasingly refer older patients for allo-HCT due to more experience and improved supportive care in allo-HCT.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.